Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 23.63 USD 8.59% Market Closed
Market Cap: 211.3m USD

Sanara Medtech Inc
Total Liabilities & Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Sanara Medtech Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Sanara Medtech Inc
NASDAQ:SMTI
Total Liabilities & Equity
$71.1m
CAGR 3-Years
5%
CAGR 5-Years
49%
CAGR 10-Years
47%
Haemonetics Corp
NYSE:HAE
Total Liabilities & Equity
$2.4B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Total Liabilities & Equity
$4.1B
CAGR 3-Years
-3%
CAGR 5-Years
19%
CAGR 10-Years
21%
Align Technology Inc
NASDAQ:ALGN
Total Liabilities & Equity
$6.2B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
19%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Liabilities & Equity
$2.3B
CAGR 3-Years
28%
CAGR 5-Years
21%
CAGR 10-Years
25%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Liabilities & Equity
$2.6B
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
13%
No Stocks Found

Sanara Medtech Inc
Glance View

Market Cap
211m USD
Industry
Health Care

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 63 full-time employees. The Company’s products include surgical wound care products, which includes CellerateRX Surgical Activated Collagen (Powder and Gel), and chronic wound care products, which include HYCOL Hydrolyzed Collagen (Powder and Gel), BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel. The surgical wound care products are used in specialties including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, oncology, plastic/reconstructive, podiatric, urology and vascular. The chronic wound care products are used across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities, and wound care centers.

SMTI Intrinsic Value
37.73 USD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Sanara Medtech Inc's Total Liabilities & Equity?
Total Liabilities & Equity
71.1m USD

Based on the financial report for Sep 30, 2025, Sanara Medtech Inc's Total Liabilities & Equity amounts to 71.1m USD.

What is Sanara Medtech Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
47%

Over the last year, the Total Liabilities & Equity growth was -20%. The average annual Total Liabilities & Equity growth rates for Sanara Medtech Inc have been 5% over the past three years , 49% over the past five years , and 47% over the past ten years .

Back to Top